Study of First-line Camrelizumab With or Without Chemotherapy for Advanced Esophageal Squamous Cell Cancer
Clinical trial NCT04654403 · UNKNOWN
Trial details
- NCT number
- NCT04654403
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-01
- Primary completion
- 2022-05-31
- Enrollment
- 337
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.